- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Newsletter
- April 2025
- 3 Pages
Global
From €124EUR$131USD£105GBP
- Report
- January 2025
- 132 Pages
Global
From €897EUR$950USD£763GBP
- Report
- August 2024
- 92 Pages
China
From €1700EUR$1,800USD£1,446GBP
- Report
- August 2024
- 214 Pages
China
From €3778EUR$4,000USD£3,213GBP
- Report
- June 2023
- 132 Pages
Global
From €897EUR$950USD£763GBP
- Report
- September 2024
- 280 Pages
Global
From €2507EUR$2,655USD£2,133GBP
- Report
- June 2023
- 296 Pages
Global
From €3371EUR$3,570USD£2,868GBP
- Report
- October 2022
- 160 Pages
Global
From €3371EUR$3,570USD£2,868GBP
- Report
- March 2022
- 254 Pages
Global
From €3367EUR$3,565USD£2,864GBP
- Book
- January 2024
North America
- Book
- February 2023
North America
- Book
- August 2021
North America

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more